Schrödinger, Inc. (SDGR)

Schrödinger, Inc. is a leading computational technology company that specializes in developing advanced molecular simulation software for drug discovery and materials science. Founded in 1990, Schrödinger has become a cornerstone in the biotech and pharmaceutical industries, leveraging physics-based chemical simulations to accelerate the research and development process. The company's flagship product, Maestro, is widely used by scientists for molecular modeling, and its platform has contributed to significant breakthroughs in creating new treatments and materials. Dr. Ramy Farid serves as the CEO, bringing extensive expertise in computational chemistry and leadership. In 2022, Schrödinger reported revenue of over $181 million, reflecting its critical role in transforming scientific research through state-of-the-art computational tools. Headquarters are located in New York City, with additional offices worldwide, underscoring its global reach and influence.